Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question
MF Neurath, S Finotto, I Fuss, M Boirivant, PR Galle… - Trends in …, 2001 - cell.com
MF Neurath, S Finotto, I Fuss, M Boirivant, PR Galle, W Strober
Trends in immunology, 2001•cell.comT-cell resistance against apoptosis contributes to inappropriate T-cell accumulation and the
perpetuation of chronic mucosal inflammation in inflammatory bowel diseases (IBDs). Anti-
interleukin-12 (IL-12) and anti-IL-6 receptor antibodies suppress colitis activity by the
induction of T-cell apoptosis. These findings have important implications for the design of
effective treatment regimens in IBD.
perpetuation of chronic mucosal inflammation in inflammatory bowel diseases (IBDs). Anti-
interleukin-12 (IL-12) and anti-IL-6 receptor antibodies suppress colitis activity by the
induction of T-cell apoptosis. These findings have important implications for the design of
effective treatment regimens in IBD.
Abstract
T-cell resistance against apoptosis contributes to inappropriate T-cell accumulation and the perpetuation of chronic mucosal inflammation in inflammatory bowel diseases (IBDs). Anti-interleukin-12 (IL-12) and anti-IL-6 receptor antibodies suppress colitis activity by the induction of T-cell apoptosis. These findings have important implications for the design of effective treatment regimens in IBD.
cell.com